Venus Concept is a medical devices business based in the US. Venus Concept shares (VERO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.48 – an increase of 5.08% over the previous week. Venus Concept employs 304 staff and has a trailing 12-month revenue of around $69.8 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.48 |
|---|---|
| 52-week range | $0.42 - $2.43 |
| 50-day moving average | $0.61 |
| 200-day moving average | $0.80 |
| Wall St. target price | $10.60 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-8.46 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.4796 from 2024-10-11
| 1 week (2024-10-07) | 5.08% |
|---|---|
| 1 month (2024-09-13) | -12.00% |
| 3 months (2024-07-12) | -22.65% |
| 6 months (2024-04-12) | -29.22% |
| 1 year (2023-10-13) | -77.48% |
|---|---|
| 2 years (2022-10-14) | 71.72% |
| 3 years (2021-10-12) | 2.06 |
| 5 years (2019-10-14) | 6.102 |
| Revenue TTM | $69.8 million |
|---|---|
| Gross profit TTM | $74.1 million |
| Return on assets TTM | -18.66% |
| Return on equity TTM | -463.54% |
| Profit margin | -71.52% |
| Book value | $0.51 |
| Market Capitalization | $3.3 million |
TTM: trailing 12 months
We're not expecting Venus Concept to pay a dividend over the next 12 months.
Venus Concept's shares were split on a 1:15 basis on 11 May 2023. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Venus Concept shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Venus Concept shares which in turn could have impacted Venus Concept's share price.
Over the last 12 months, Venus Concept's shares have ranged in value from as little as $0.417 up to $2.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Venus Concept's is 0.6. This would suggest that Venus Concept's shares are less volatile than average (for this exchange).
Venus Concept Inc. , a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI. ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.